Indications and uses
Uses temporarily relieves minor aches and pains due to: headache muscular aches the common cold toothache menstrual cramps backache minor pain of arthritis temporarily reduces fever
Uses temporarily relieves minor aches and pains due to: headache muscular aches the common cold toothache menstrual cramps backache minor pain of arthritis temporarily reduces fever
Directions do not take more than directed the smallest effective dose should be used drink a full glass of water with each dose adults and children 12 years and older take 1 tablet every 8 to 12 hours while symptoms last for the first dose you may take 2 tablets within the first hour do not exceed 2 tablets in any 8- to 12-hour period do not exceed 3 tablets in a 24-hour period children under 12 years: ask a doctor
Drug Facts
Active ingredient
Naproxen sodium 220 mg (naproxen 200 mg) (NSAID)*
*nonsteroidal anti-inflammatory drug
Purpose
Pain reliever/fever reducer
Uses
Warnings
Warnings: Naproxen sodium may cause a severe allergic reaction, especially in people allergic to aspirin.
Symptoms may include:
If an allergic reaction occurs, stop use and seek medical help right away.
Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you
Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.
Do not use
Ask a doctor before use if
Ask a doctor or pharmacist before use if you are
When using this product
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use naproxen sodium at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
Other information
Inactive ingredients croscarmellose sodium, FD&C blue #2 aluminum lake, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, povidone, silicon dioxide, talc, titanium dioxide
Questions or comments?1-877-507-6516 (M-F 8 AM-4:30 PM CT)
24/7 Life
BY 7-ELEVEN ™
Naproxen
Naproxen Sodium Tablets, 220 mg (NSAID)
Pain Reliever/Fever Reducer
STRENGTH TO LAST 12 HOURS
compare to
Aleve ® Tablets
active ingredient +
24
TABLETS
Actual Size [tablet image]
| Class | Version | Type | Effective |
|---|---|---|---|
| NAPROXEN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20191108 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fef6ad89-235f-4274-ba49-a8e53642473e | Product name | 2 | 20250225 |
| 87fed3e6-8fba-48ef-96b0-3a7fb54b96ff | Product name | 3 | 20230306 |
| b5fdaaec-7251-4da6-9cb2-4e9e76939ec8 | Product name | 1 | 20200623 |
| e76dbbc1-775d-722c-08ff-ed45e8a80def | Product name | 3 | 20181002 |
| 6f4f4521-fd56-1ae6-888b-3b021bd75c7c | Product name | 1 | 20140508 |
| ce67e27d-1d21-5465-4409-b0662dd99d4d | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66715-5428-4 | 24/7 Life by 7-Eleven Naproxen Sodium | 24 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 24 | 1 | |
| 66715-5428-4 | 24/7 Life by 7-Eleven Naproxen Sodium | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 66715-5428 | 66715-5428-4 |
Every source-derived ingredient row is available through these pages.
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A204872-001 | NAPROXEN SODIUM | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A204872-001 | NAPROXEN SODIUM | EQ 200MG BASE | TABLET / ORAL | 2017-01-23 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A204872-001 | NAPROXEN SODIUM | EQ 200MG BASE | TABLET / ORAL | 2017-01-23 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 3a93d1ddd44b… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 24/7 Life by 7-Eleven Naproxen Sodium | NAPROXEN SODIUM TABLET, FILM COATED | Lil' Drug Store Products, Inc. | 44716954-006a-4c56-e063-6294a90a0f14 | 2025-11-25 | Warnings | 66715-5428-4 66715-5428 66715542804 44716954-006b-4c56-e063-6294a90a0f14 44716954-006a-4c56-e063-6294a90a0f14 |
Adverse event summaries are temporarily unavailable. Other product information remains available.